Ceporex Vet | 
Ceporex Vet contains cefalexin, a broad spectrum antibiotic widely used for soft tissue infections in dogs and cats. Antibiotic sensitivity testing is used where possible to confirm that Ceporex is active against the bacteria involved in any particular infection. However its broad spectrum of activity and ability to get into a wide variety of body tissues, means that Ceporex is a good choice of antibiotic for a wide range of infections even without laboratory confirmation. It is normally dosed twice daily in dogs and cats, at a dose rate of 15-30mg/kg bodyweight.
| | | | |
|  | Customers who purchased these items also purchased |   | | Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction 
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Film-coated tablets containing 50 mg Cefalexin (as 52.6 mg Cefalexin monohydrate).
Round, convex, pink film-coated tablets embossed with “Ceporex 50” on one side.
Uses
The tablets are indicated for oral antibiotic therapy in cats and dogs. Cefalexin is a broad spectrum cephalosporin antibiotic with bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria.
The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp. (including penicillin-resistant strains), Streptococcus spp., Corynebacterium spp., Pasteurella multocida, Escherichia coli, Micrococcus spp., Moraxella spp.
When susceptible organisms are present, the tablets may be effective in the treatment of infections of the respiratory tract, urogenital tract, the skin and localised infections in soft tissue.
In dogs it may also be effective in the treatment of infections of the gastrointestinal tract.
Cefalexin is rapidly, and almost completely, absorbed after oral administration. Effective blood levels are generally achieved within two hours of dosing. Cefalexin is excreted in the urine in a high concentration.
Dosage and administration
The recommended dose rate is 10 to 15 mg/kg bodyweight twice daily.
The following is intended as a guide.
Dogs
5 kg or less bodyweight: 1×50 mg tablet twice daily.
6 to 9 kg bodyweight: 2×50 mg tablets twice daily.
Cats
Average dose rate: 1×50 mg tablet twice daily.
Treatment for five days is recommended.
Any variation should be at the discretion of the prescribing veterinary surgeon, e.g. in cases where the condition requires an extended course of treatment (such as chronic pyoderma).
The tablets are well accepted by cats and dogs but may be crushed or added to food if necessary.
Contra-indications, warnings, etc
Do not use the product in animals which are known to be hypersensitive to cefalexin.
Do not use in rabbits, guinea pigs, hamsters and gerbils.
The safety of the product has not been demonstrated in studies in pregnant or lactating dogs. Use only in accordance with benefit/risk assessment by the responsible veterinary surgeon.
Hypersensitivity to cefalexin is rare.
The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced and the product used in accordance with a benefit/risk assessment by the responsible veterinarian.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information about susceptibility of the target bacteria and take into account official, national and regional antimicrobial policies.
The use of antibiotics, especially penicillins and cephalosporins, has been associated with potentially fatal antibiotic enterotoxaemia, particularly in rabbits.
Operator warnings
Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1.Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2.Handle this product with great care to avoid exposure, taking all recommended precautions.
3.If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.
Withdrawal period
Not applicable.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal advice
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Legal category
POM-V
Packaging Quantities
The Tablets are supplied in packs of 100 and 500 tablets.
Further information
Nil.
Marketing authorisation number
Vm 00201/4074.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Film-coated tablets containing 250 mg Cefalexin (as 263 mg Cefalexin monohydrate).
Round, convex, pink film-coated tablets embossed with “Ceporex 250” on one side.
Uses
The tablets are indicated for oral antibiotic therapy in dogs. Cefalexin is a broad spectrum cephalosporin antibiotic with bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria.
The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp. (including penicillin-resistant strains), Streptococcus spp., Corynebacterium spp., Pasteurella multocida, Escherichia coli, Micrococcus spp, Moraxella spp.
When susceptible organisms are present, the tablets may be effective in the treatment of infections of the respiratory tract, urogenital tract, the skin and localised infections in soft tissue.
In dogs it may also be effective in the treatment of infections of the gastrointestinal tract.
Cefalexin is rapidly, and almost completely, absorbed after oral administration. Effective blood levels are generally achieved within two hours of dosing. Cefalexin is excreted in the urine in a high concentration.
Dosage and administration
The recommended dose rate is 10 to 15 mg/kg bodyweight twice daily.
The following is intended as a guide.
Dogs
10 to 25 kg bodyweight:
| 1 x 250 mg tablet twice daily.
| 26 to 50 kg bodyweight:
| 2×250 mg tablets twice daily.
| 51 kg and over bodyweight:
| 3×250 mg tablets twice daily.
|
Treatment for five days is recommended.
Any variation should be at the discretion of the prescribing veterinary surgeon, e.g. in cases where the condition requires an extended course of treatment (such as chronic pyoderma).
The tablets are well accepted by dogs but may be crushed or added to food if necessary. Contra-indications, warnings, etc
Do not use the product in animals which are known to be hypersensitive to cefalexin.
Do not use in rabbits, guinea pigs, hamsters and gerbils.
The safety of the product has not been demonstrated in studies in pregnant or lactating dogs. Use only in accordance with benefit/risk assessment by the responsible veterinary surgeon.
Hypersensitivity to cefalexin is rare.
The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced and the product used in accordance with a benefit/risk assessment by the responsible veterinarian.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information about susceptibility of the target bacteria and take into account official, national and regional antimicrobial policies.
The use of antibiotics, especially penicillins and cephalosporins, has been associated with potentially fatal antibiotic enterotoxaemia, particularly in rabbits.
Operator warnings
Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1.Do not handle this product (or these products) if you know you are sensitised, or if you have been advised not to work with such preparations.
2.Handle this product with great care to avoid exposure, taking all recommended precautions.
3.If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.
Withdrawal period
Not applicable.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal advice
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Legal category
POM-V
Packaging Quantities
The Tablets are supplied in packs of 100 and 250 tablets.
Further information
Nil.
Marketing authorisation number
Vm 00201/4075.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Film-coated tablets containing 500 mg Cefalexin (as 526 mg cefalexin monohydrate).
Round, convex, pink film-coated tablets, embossed with “Ceporex 500” on one side.
Uses
The tablets are indicated for oral antibiotic therapy in dogs.
When susceptible organisms are present, the product may be effective in the treatment of infections of the respiratory tract, urogenital tract, the skin and localised infections in soft tissue. In dogs it may also be effective in the treatment of infections of the gastro-intestinal tract.
Dosage and administration
The recommended dose rate is 10 to 15 mg/kg bodyweight twice daily.
To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
The following is intended as a guide:
Dogs: |
26 to 50 kg bodyweight: |
1 x 500 mg tablet twice daily. | |
51 kg and over body weight: |
2 x 500 mg tablets twice daily. |
Treatment for five days is recommended. Any variation should be at the discretion of the prescribing veterinary surgeon, e.g. in cases where the condition requires an extended course of treatment (such as chronic pyoderma).
Administration: by the oral route. The product may be crushed or added to food if necessary, provided the dog is eating.
Contra-indications, warnings, etc
Do not use the product in animals which are known to be hypersensitive to cefalexin.
Do not use in rabbits, guinea pigs, hamsters and gerbils.
The safety of the product has not been demonstrated in studies in pregnant or lactating dogs. Use only in accordance with benefit/risk assessment by the responsible veterinarian.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced and the product used in accordance with a benefit/risk assessment by the responsible veterinarian.
Hypersensitivity to cefalexin is rare.
The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information about susceptibility of the target bacteria and take into account official, national and regional antimicrobial policies.
The use of antibiotics, especially penicillins and cephalosporins, has been associated with potentially fatal antibiotic enterotoxaemia, particularly in rabbits.
Operator warnings
Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2. Handle this product with great care to avoid exposure, taking all recommended precautions. Wash hands after use.
3. If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.
Withdrawal period
Not applicable.
For animal treatment only. Keep out of reach and sight of children.
Pharmaceutical precautions
Do not store above 25°C. Protect from light.
Disposal advice
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Legal category
POM-V
Packaging Quantities
White, opaque, polypropylene tub with a white polyethylene cap containing 100, 250 or 500 tablets.
Cardboard carton containing 200 tablets supplied in strips of 10 tablets in PVC film/aluminium foil blisters. Not all pack sizes may be marketed.
Further information
Nil.
Marketing authorisation number
Vm 00201/4189.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Ceporex Injection is an oily suspension of sodium cefalexin equivalent to 18% w/v cefalexin Ph.Eur.
Uses
Ceporex Injection is indicated for antibiotic therapy in cattle, cats and dogs. Cefalexin is a broad spectrum cephalosporin antibiotic with bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria.
The following micro-organisms have been shown to be sensitive to cefalexin in vitro:
Staphylococcus spp. (including penicillin-resistant strains)
Streptococcus spp.
| Actinomyces bovis
| Corynebacterium spp.
| Haemophilus spp.
| Pasteurella spp.
| Erysipelothrix rhusiopathiae
| Escherichia coli
| Clostridium spp.
| Proteus spp.
| Salmonella spp.
| Micrococcus spp.
| Fusobacterium spp.
| Moraxella spp.
| Peptostreptococcus spp.
| Actinobacillus lignieresi
| Peptococcus spp.
|
When susceptible organisms are present, Ceporex Injection is indicated in the treatment of infections of the respiratory tract, urogenital tract, the skin and localised infections in soft tissues in dogs and cats. In dogs it may also be effective in the treatment of the gastrointestinal tract.
Trials have shown Ceporex Injection to be of particular value in treating the following: Cattle: Metritis, foot infections, wounds and abscesses and in the treatment of septicaemic mastitis to supplement intramammary therapy. Dosage and administration
In the presence of water hydrolysis of cefalexin occurs. It is important, therefore, that a dry syringe is used when extracting suspension for injection to avoid contaminating the remaining contents of the vial with drops of water.
Before withdrawal of a dose the vial should be shaken to re-suspend the contents.
Dogs and cats
The recommended dose is 10 mg/kg once daily for up to 5 days. Any variation should be at the prescribing veterinary surgeons discretion, e.g. in severe or acute conditions. The following is intended as a guide:
Animal
| Weight
| Dose volume
| Cats: up to
| 4.5 kg
| 0.25 ml
| Dogs: small
| 5–9.0 kg
| 0.25–0.5 ml
| medium
| 9.0–27.0 kg
| 0.5–1.5 ml
| large
| 27.0–54.0 kg
| 1.5–3.0 ml
|
Ceporex Injection may be administered by either the subcutaneous or intramuscular route. After administration massage the injection site. Ceporex Injection is not suitable for intravenous or intrathecal administration. Large animals
The recommended dose for cattle is 7 mg/kg once daily for up to 5 days. Species
| Dose rate
| Dose volume
| Cattle
| 7 mg/kg
| 1 ml/25 kg
|
Ceporex Injection should be administered by the intramuscular route. It is not suitable for intravenous administration.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced. Contra-indications, warnings, etc
Hypersensitivity to cefalexin is rare. However, Ceporex Injection should not be administered to animals which are known to be hypersensitive to cefalexin.
Operator warnings
Care should be taken to avoid accidental self-injection. In the case of accidental self-injection, seek medical advice immediately. Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross sensitivity to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
1.Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2.Handle this product with great care to avoid exposure taking all recommended precautions.
3.If you develop symptoms following exposure as a skin rash you should seek medical advice and show the Doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.
Use of the product may result in localised tissue reaction.
Wash hands after use.
For animal treatment only
Keep out of the reach and sight of children
Large animals
Withdrawal period for cows' milk - zero hours.
Animals for human consumption must not be slaughtered during treatment. Withdrawal periods for animals for human consumption when treated with Ceporex Injection at the recommended dosage are as follows:
Cattle: 19 days after last treatment.
Pharmaceutical precautions
Protect from light. Do not store above 30°C.
Shake well before use.
After withdrawal of the first dose, use the product within 28 days. When the container is broached for the first time, use the in-use shelf life which is specified on the packaging to calculate the date on which any remaining product should be discarded. This discard date should be written in the space provided on the label. Discard unused material. This product does not contain an antimicrobial preservative. Swab the septum before removing each dose. Use a dry, sterile needle and syringe.
Disposal
Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon. Do not mix with any other veterinary product.
Legal category
POM-V
Packaging Quantities
Multidose vials 100 ml.
Further information
Cefalexin is rapidly absorbed after injection. Peak blood concentrations are generally achieved within one hour of administration. Cefalexin is excreted in the urine in high concentration.
Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase. Cefalexin is also active against the majority of ampicillin-resistant E. coli.
Where extended therapy is required for dogs and cats (e.g. chronic skin infections) Ceporex Tablets or Ceporex Vet Oral Drops may be used following initial treatment by injection.
Marketing authorisation number
Vm 00201/4139.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication. Introduction
Company name: MSD Animal Health
Address: Walton Manor
Walton
Milton Keynes
MK7 7AJ
Telephone: 01908 685685 (Customer Support Centre)
Fax: 01908 685555
Email: vet-support.uk@merck.com
Website: www.msd-animal-health.co.uk
Presentation
Ceporex Vet Oral Drops are presented as pale orange granules with a characteristic odour for reconstitution with water to give a sweetened orange-coloured suspension (syrup) containing 100 mg/ml cefalexin.
Uses
As a broad spectrum antibiotic with bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria, for use in cats and small dogs.
The product is effective against the following micro-organisms in vitro: Staphylococcus spp (including penicillin-resistant strains), Streptococcus spp, Corynebacterium spp, Pasteurella multocida, Escherichia coli, Micrococcus spp, Moraxella spp.
When susceptible organisms are present, Ceporex Vet Oral Drops may be effective in the treatment of infection of the respiratory tract, urogenital tract, the skin and localised infections, in soft tissue.
In dogs it may also be effective in the treatment of infections of the gastrointestinal tract.
Dosage and administration
Ceporex Vet Oral Drops are prepared by adding 6 ml of drinking water to the granules and mixing thoroughly before each withdrawal from the bottle. Administer directly into the mouth or added to food.
The recommended dose rate is 10 to 15 mg/kg bodyweight (equivalent to 1.0 to 1.5 ml Ceporex Vet Oral Drops per 10 kg bodyweight) twice daily.
Treatment for five days is recommended.
The following is intended as a guide:
Dogs
11 kg to 20 kg bodyweight: 1 to 3 ml drops twice daily.
6 kg to 10 kg bodyweight: 0.5 to 1.5 ml drops twice daily.
5 kg and less bodyweight: 0.5 to 1.0 ml drops twice daily.
Cats
Average dose rate: 0.5 ml drops twice daily.
Any variation should be at the discretion of the prescribing veterinary surgeon, e.g. in cases where the condition requires an extended course of treatment (such as chronic pyoderma).
Contra-indications, warnings, etc
Contra-indications
Do not administer to animals which are known to be hypersensitive to cefalexin. In cases of known renal insufficiency, the dose of the product should be reduced.
Operator warnings
Cephalosporins may cause sensitisation (allergy) following injection, inhalation, ingestion or skin contact. Sensitivity to penicillin may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious.
1.Do not handle this product (or these products) if you know you are sensitised, or if you have been advised not to work with such preparations.
2.Handle this product with great care to avoid exposure, taking all recommended precautions.
3.If you develop symptoms following exposure such as a skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.
Wash hands after use of this product.
For animal treatment only. Keep out of the reach and sight of children.
Pharmaceutical precautions
Protect from light. Do not store above 25°C.
When reconstituted, do not store above 25°C and preferably in a refrigerator; any reconstituted product remaining ten days after preparation should be discarded.
Shake the bottle before withdrawing each dose.
Disposal
Dispose of empty packaging and any remaining product in the household refuse.
Legal category
POM-V
Packaging Quantities
Bottles of granules for oral suspension to make up 10 ml. A graduated plastic dropper is supplied with each pack.
Further information
Cefalexin is rapidly, and almost completely, absorbed after oral administration. Effective blood levels are generally achieved within two hours of dosing. Cefalexin is excreted in the urine in high concentration.
Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase. Cefalexin is also active against the majority of ampicillin-resistant E. coli.
The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.
Marketing authorisation number
Vm 00201/4076.
| 
![Nobivac <b>DHPPi</b> Injection » <b>10 Doses</b<!--[SPECIAL DELIVERY]--><!--POM-V-->](images/viovet_1246436156_24.gif "Nobivac <b>DHPPi</b> Injection » <b>10 Doses</b<!--[SPECIAL DELIVERY]--><!--POM-V-->")
![Nobivac <b>Lepto 2</b> Injection » <b>10 x 1 Dose</b><!--[SPECIAL DELIVERY]--><!--POM-V-->](images/created_1283850185.png "Nobivac <b>Lepto 2</b> Injection » <b>10 x 1 Dose</b><!--[SPECIAL DELIVERY]--><!--POM-V-->")
